Zai Lab (ZLAB) announced positive topline results from the company’s Phase 3 multi-center trial evaluating the safety and efficacy of KarXT or xanomeline and trospium chloride, in China. Consistent ...
- Findings support advancement of ZL-6201 into Investigational New Drug (IND)-enabling studies in 2025 as a potential first-in-class and best-in-class antibody-drug conjugate (ADC) treatment for ...
Coachella celebrates 20 years of the Do Lab’s water guns, surprise sets and continuous dance parties
If you were to go to the Do Lab 20 years ago, you would’ve been greeted with orange slices, water guns and the sounds of unsanctioned DJ sets under a small geometric dome. “Our life was a lot more ...
Zai Lab Presents New Preclinical Data Suggesting ZL-1503, an IL-13/IL-31Rα Bispecific Antibody, Provides Rapid Itch Relief and Reduction in Inflammation in Atopic Diseases -Efficacy and safety data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results